rheumatology
Medicines

Glucosamine cardiovascular ‘benefits’ don’t stand up to scrutiny

A UK observational study purporting to show that glucosamine may reduce cardiovascular disease has been met with scepticism by Australian experts. Published in the BMJ, the analysis of data from 466,039 people without cardiovascular disease found a 15% lower risk of cardiovascular events  during seven years of follow up among those who reported using glucosamine ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic